Albert Collinson
Director/Board Member bei HBM HOLDINGS LIMITED
Profil
Albert R.
Collinson is currently an Independent Non-Executive Director at HBM Holdings Ltd.
and the President & Director at IncreVet, Inc. He previously served as the President at Theracos, Inc. Prior to his current roles, he held positions as the Senior Vice President-Business Development at Phylos, Inc., Vice President-Global R&D Licensing at BASF Pharma Ltd., and Chief Business Officer at Melinta Subsidiary Corp.
Dr. Collinson completed his undergraduate degree at the University of Rhode Island and obtained a doctorate degree from Brandeis University.
Aktive Positionen von Albert Collinson
| Unternehmen | Position | Beginn |
|---|---|---|
| HBM HOLDINGS LIMITED | Director/Board Member | 13.07.2023 |
Theracos, Inc.
 Theracos, Inc. Pharmaceuticals: MajorHealth Technology Theracos, Inc. operates as a pharmaceutical research and development company. The firm supports preclinical & clinical research & development in inflammatory, metabolic and affective disorders. It specializes in all aspects of pharmaceutical development including medicinal and process chemistry, pharmacology, toxicology, pharmacokinetics, manufacturing, formulation, QA/QC, regulatory affairs and the design and execution of clinical trials. The company was founded by Edward P. Amento and is headquartered in Marlborough, MA. | President | 01.07.2009 |
IncreVet, Inc.
 IncreVet, Inc. Pharmaceuticals: MajorHealth Technology Part of Theracos, Inc., IncreVet, Inc. develops veterinary drugs. The private company is based in Marlborough, MA. The company was founded by Brian Connelly. IncreVet was acquired by Theracos, Inc. on January 31, 2022. | President | - |
Ehemalige bekannte Positionen von Albert Collinson
| Unternehmen | Position | Ende |
|---|---|---|
Phylos, Inc.
 Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Corporate Officer/Principal | - |
Ausbildung von Albert Collinson
| University of Rhode Island | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Commercial Services |
BASF Pharma Ltd.
BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The private company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Health Technology |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Theracos, Inc.
Theracos, Inc. Pharmaceuticals: MajorHealth Technology Theracos, Inc. operates as a pharmaceutical research and development company. The firm supports preclinical & clinical research & development in inflammatory, metabolic and affective disorders. It specializes in all aspects of pharmaceutical development including medicinal and process chemistry, pharmacology, toxicology, pharmacokinetics, manufacturing, formulation, QA/QC, regulatory affairs and the design and execution of clinical trials. The company was founded by Edward P. Amento and is headquartered in Marlborough, MA. | Health Technology |
IncreVet, Inc.
IncreVet, Inc. Pharmaceuticals: MajorHealth Technology Part of Theracos, Inc., IncreVet, Inc. develops veterinary drugs. The private company is based in Marlborough, MA. The company was founded by Brian Connelly. IncreVet was acquired by Theracos, Inc. on January 31, 2022. | Health Technology |
